🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎥 Exclusive interview this morning at #ESTRO25: We spoke with ESTRO President Prof Matthias Guckenberger about the congress highlights, this year’s theme of partnership, and the future of radiation oncology. Don’t miss his insights ⬇️ #Radiotherapy #CancerResearch Matthias Guckenberger

Giulio Francolini ESTRO Piet Ost We would like to inform you that your post has been published on OncoDaily. Thank you for sharing such valuable content. oncodaily.com/url/287260

An honor to moderate this session featuring Late-Breaking papers: 🌟PORTEC-4a 🌟PEACE V – STORM 🌟First RAPID-RT analysis Many compliments to the speakers and discussants! #ESTRO2025

Join us for #ESTRO26 in Stockholm!!!

☢️SBRT for kidney cancer: Wonderful joint ESTRO-ASTRO symposium with fantastic speakers. The future is really bright! ⚡ Bradley Stish Giulia Marvaso Michiel Strijbos #estro25 ESTRO

#2 from My Co-Chair Session #ESTRO25 Can SBRT Add Value to Apalutamide in Oligometastatic HSPC? (Interim analysis from the PERSIAN trial – NCT05717660) by Giulio Francolini 🎯 mHSPC, <5 metachronous lesions 🧪 Arm A: Apalutamide + ADT 🆚 Arm B: Apalutamide + ADT + SBRT Complete

📢Very Happy to co-chair a fantastic last GU session about bladder cancer, state of the art and areas of improvement. ESTRO #ESTRO25

Great honor to be at #ESTRO25 to discuss the bladder sparing approach with medical tx alone in #MIBC. Challenging topic pending EV-P combo in EV304 study. Patient's selection remains critical. Robert Huddart💙 Valérie Fonteyne Giulio Francolini Stefano Arcangeli OncoAlert World Bladder Cancer Patient Coalition

🎩🎩 off to 🇮🇹 Giulio Francolini Giulia Marvaso and Ciro Franzese for handling the GU sessions #ESTRO25 so well, either as chairs or speakers ⚡️so inspiring for the younger colleagues 🤩 #ProstateCancer #radonc ESTRO

Fabio Arcidiacono ESTRO Radiotherapy & Oncology Stefano Arcangeli Giulio Francolini Federica Ferrario Giulia Marvaso prof. Barbara Jereczek-Fossa We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing! oncodaily.com/blog/fabio-arc…

Tomorrow, SYNERGY kicks off! The opening session will focus on #RCC with YAU RCC colleagues. Looking forward to sessions on #bladder, #prostate, and a global #MDT perspective.

#PERSIAN trial explores SBRT benefits in oligometastatic hormone-sensitive #ProstateCancer. Giulio Francolini Azienda Ospedaliero-Universitaria Careggi sits down with Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute to discuss SBRT added to ADT plus apalutamide in oligometastatic #HSPC. Preliminary analysis of 87 patients shows a

Was a great SYNERGY meeting Congratulations for fruitful 2 days with science, academia and friendship. My friend, Savio Domenico Pandolfo The future of Unina Federico II and Università degli Studi dell'Aquila is brilliant in your hands with the guidance of Prof. Ciro Imbimbo EAU-YAU Renal Cancer Working Group Riccardo Campi Daniele Amparore

Heart matters!🫀❤️ #Cardioprotection in #anthracycline treated #BreastCancer patients: final analysis from the 2x2 randomized, placebo-controlled, double-blind SAFE trial Article link: authors.elsevier.com/sd/article/S20… Università di Firenze Azienda Ospedaliero-Universitaria Careggi ESMO Open OncoAlert #OncoAlert

Meet the team! Daniele Amparore Riccardo Campi 𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD Eduard Roussel Michele Marchioni Carlotta Palumbo Laura Marandino Zhenjie Wu, MD, PhD Savio Domenico Pandolfo Angela Pecoraro Umberto Carbonara Leonardo D. Borregales, MD Hannah Warren Giulio Francolini Chiara Ciccarese veronica mollica Gaëlle Margue Umberto Carbonara

Congratulations to Dr. Giulio Francolini, the recipient of Reviewer Recognition Award! Your commitment to maintaining the high standards of our journal helps keep us at the forefront of oncological urological research. Thank you! #UroSoMe #Urology #ReviewerRecognitionAward

📹 Tune in to this video discussion between UROONCO RCC associate editor Dr. 𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD and Dr. Pieter De Backer , talking about auxiliary technologies in robotic surgery and the use of AI for intra-operative visual guidance. Learn more here kidney.uroonco.uroweb.org/video/auxiliar…👇 #kidneycancer

Great presentations & Case discussions Our members are in the podium during European Association of Urology (EAU) #UROonco25 meeting Daniele Amparore Riccardo Campi Laura Marandino Carlotta Palumbo

🥳 Today, we randomised the final patient on Trans Tasman Radiation Oncology Group 19.06 DECREASE trial! This trial randomised patients with prostate cancer who were becoming resistant to hormone therapy, without evidence of metastases on bone or CT scan, to Darolutamide +/- Stereotactic

Excited to share our newest paper on digital pathology AI biomarkers in prostate cancer RT. In this work we: ▶️performed a systematic review ▶️checked ongoing trials ▶️collected an expert consensus sciencedirect.com/science/articl… Thanks Radiotherapy & Oncology for accepting this work